comparative study to evaluate efficacy of nerve block using local anaesthetic drug (ropivacaine) for positioning to give spinal/epidural anaesthesia

Not yet recruiting

• Conditions: Fracture of head and neck of femur, (2) ICD-10 Condition: O||Medical and Surgical,

• Registration Number: CTRI/2023/04/052061
• Lead Sponsor: ESIC Medical college and hospital

Brief Summary

PURPOSE : A comparative study between Pericapsular nerve group block and Femoral nerve block using 25ml of 0.2% Ropivacaine for ease of positioning to central neuraxial block for Hip surgeries.

DESIGN : RANDOMIZED,CONTROLLED TRAIL

PARTICIPANT AND CONTROL : Patients undergoing Hip surgeries will be Randomly allocated to one of the two groups based on computer generated random number.

INTERVENTION : Site of injection is marked, under strict aseptic precautions and USG guided 25ml Local anaesthetic agent is administered after negative aspiration.

Inj. Ropivacaine 0.2% 25ml is administered in incremental dose after negative aspiration for every 5ml using 22G Spinal needle or 10cm stimiplex block needle.

Group P will receive 25mls of 0.2% Ropivacaine for pericapsular nerve group block

Group F will receive 25mll of 0.2% Ropivacaine for femoral nerve block

Vitals and VAS score is monitored from time of injection till position for central neuraxial block.

Pain Score and Angle of sitting position to administer central neuraxial block is noted.

MAIN OUTCOME MEASURES : Efficacy of Pericapsular nerve group block for positioning of patient for central neuraxial block

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-05
• Last Update Posted: 2023-04-26

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Male
• Target Recruitment: 78

Inclusion Criteria

1. Patients of either sex, 2) 50–90 years of age, 3) American Society of Anesthesiologists (ASA) physical grading I–III were included in the study.

Exclusion Criteria

1. Exclusion criteria included patient refusal to participate in the study, 2) Presence of any coagulation disorders, 3) Presence of multiple fractures, 4) Any patients with head injury or other injuries,.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Efficacy of PENG block	40mins
2.Ease of positioning for central neuraxial block	40mins

Secondary Outcome Measures

Name	Time	Method
not applicable	not applicable

Trial Locations

Locations (1)

ESIC Medical college and hospital; 🇮🇳 Hyderabad, TELANGANA, India

ESIC Medical college and hospital

🇮🇳Hyderabad, TELANGANA, India

Dr Saka Dheeraj kumar

Principal investigator

9620132612

dheerajkumar.saka@gmail.com